In accordance with the results from spheroid cells and TMZ-treated GBM cells, we showed that CEBPD serves as a key regulator of TMZ resistance in GBM by regulating SOX2, OCT4, NANOG, and ABCA1 at the molecular and transcriptional levels. The gene discussed is NANOG; the disease is glioblastoma.